Skip to main content
Clinical Trials/CTRI/2018/05/014303
CTRI/2018/05/014303
Recruiting
未知

A Non-Interventional, Multicenter, Prospective, Observational Study to Understand Usage and Effect of AZilsartan as MonothErapy or Add On TreatmeNt in Indian PaTients with Hypertension - ZENITH

Torrent Pharmaceuticals Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Torrent Pharmaceuticals Ltd
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient willing to provide informed consent
  • 2\.Female or male patient aged 18 years or above
  • 3\.A treatment naive patient or a patient who are on treatment with other antihypertensive with grade 1 and 2 hypertension (SBP between 150 to 180\)
  • 4\.Physician decides to prescribe azilsartan as a monotherapy or add\-on
  • 5\.Patients must provide written consent to use personal and/or health data prior to the entry into the study

Exclusion Criteria

  • 1\.Confirmed secondary hypertension
  • 2\.Patient taking a medicine acts upon RAAS e.g. ACEi or ARBs other than Azilsartan
  • 3\.Contraindications for azilsartan of respective approved local prescribing information.
  • 4\.Any reasons of medical and non\-medical character, which in the opinion of the physician can prevent subject participation in the study
  • 5\.Pregnant and lactating woman and women of child bearing potential not ready to use an effective barrier contraceptive method during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials